MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma

被引:19
|
作者
Zhang, Huiming [1 ]
Liu, Shuang [1 ]
Chen, Liqiang [1 ]
Sheng, Yanliang [1 ]
Luo, Wenzhe [1 ]
Zhao, Gang [2 ]
机构
[1] Jiamusi Univ, Sch Basic Med, 258 Xuefu Rd, Jiamusi, Heilongjiang, Peoples R China
[2] Jiamusi Univ, Sch Stomatol, Jiamusi, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma (HCC); miR-509-3p; Twist; epithelial-mesenchymal transition (EMT); invasion; metastasis; CELL-PROLIFERATION; CANCER STATISTICS; EXPRESSION; PROMOTES; INVASION; GENE; SORAFENIB; APOPTOSIS; GROWTH; TWIST;
D O I
10.1080/21655979.2021.1932210
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Our study seeks to obtain data which help to assess the impacts and related mechanisms of microRNA miR-509-3p in hepatocellular carcinoma (HCC). We found that the expression of miR-509-3p was down-regulated and Twist was up-regulated in HCC tissues and cell lines (HepG2, HCCLM3, Bel7402, and SMMC7721) compared with the adjacent normal tissues and normal human hepatocyte (L02). Moreover, cell proliferation, invasion, migration and epithelial-mesenchymal transition (EMT) in HepG2 and HCCLM3 cells were appeared to be markedly suppressed by overexpressed miR-509-3p. Overexpression of miR-509-3p also performed inhibition of the growth and metastasis in vivo. In addition, miR-509-3p could target and inhibit Twist expression, and it could further reverse the tumor promotion by Twist in HCC. All in all, miR-509-3p overexpression causes inhibition of the proliferation, migration, invasion and EMT of HCC cells by negatively regulating Twist, thereby suppressing HCC development and metastasis.
引用
收藏
页码:2263 / 2273
页数:11
相关论文
共 50 条
  • [1] miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
    Chen, Jing-song
    Liang, Li-li
    Xu, Hong-xu
    Chen, Fan
    Shen, Shun-li
    Chen, Wei
    Chen, Lian-Zhou
    Su, Qiao
    Zhang, Long-juan
    Bi, Jiong
    Zeng, Wen-Tao
    Li, Wen
    Ma, Ning
    Huang, Xiao-Hui
    ONCOTARGET, 2017, 8 (42) : 71418 - 71429
  • [2] Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
    Yao, Ting
    Hu, Weiwei
    Chen, Jinmei
    Shen, Leer
    Yu, Yongsheng
    Tang, Zhenghao
    Zang, Guoqing
    Zhang, Yi
    Chen, Xiaohua
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (05) : 2472 - +
  • [3] miR-509-5p and miR-1243 inhibit epithelial-mesenchymal transition in pancreatic cancer.
    Hiramoto, Hidekazu
    Muramatsu, Tomoki
    Ichikawa, Daisuke
    Otsuji, Eigo
    Inazawa, Johji
    CANCER SCIENCE, 2018, 109 : 601 - 601
  • [4] Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
    Yan, Yi-Quan
    Xie, Juan
    Wang, Jing-Fu
    Shi, Zhao-Feng
    Zhang, Xiang
    Du, Yong-Ping
    Zhao, Xing-Cheng
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (07) : 645 - 654
  • [5] MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
    Shu-peng Chen
    Bao-xin Liu
    Jie Xu
    Xiao-feng Pei
    Yi-ji Liao
    Feng Yuan
    Fang Zheng
    BMC Cancer, 15
  • [6] MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
    Chen, Shu-peng
    Liu, Bao-xin
    Xu, Jie
    Pei, Xiao-feng
    Liao, Yi-ji
    Yuan, Feng
    Zheng, Fang
    BMC CANCER, 2015, 15
  • [7] MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
    Yu, Shuo
    Jing, Li
    Yin, Xiao-Ran
    Wang, Min-Cong
    Chen, Yi-Meng
    Guo, Ya
    Nan, Ke-Jun
    Han, Li-Li
    ONCOTARGET, 2017, 8 (59) : 99757 - 99771
  • [8] MicroRNA control of epithelial-mesenchymal transition and metastasis
    Zhang, Jinsong
    Ma, Li
    CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) : 653 - 662
  • [9] miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4
    Dou, Changwei
    Liu, Zhikui
    Xu, Meng
    Jia, Yuli
    Wang, Yufeng
    Li, Qing
    Yang, Wei
    Zheng, Xin
    Tu, Kangsheng
    Liu, Qingguang
    CANCER LETTERS, 2016, 381 (02) : 380 - 390
  • [10] Epithelial-mesenchymal transition in hepatocellular carcinoma
    van Zijl, Franziska
    Zulehner, Gudrun
    Petz, Michaela
    Schneller, Doris
    Kornauth, Christoph
    Hau, Mara
    Machat, Georg
    Grubinger, Markus
    Huber, Heidemarie
    Mikulits, Wolfgang
    FUTURE ONCOLOGY, 2009, 5 (08) : 1169 - +